Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (7,588)	$ (6,806)
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to gain on sale of Portamedic	0	(1,204)
Gain on sale of real estate, net	0	(1,830)
Depreciation and amortization	1,546	912
Amortization of debt discount	430	0
Amortization of deferred financing fees	328	260
Provision for bad debt expense	26	195
Share-based compensation expense	360	454
Loss on disposal of fixed assets and other	0	83
Change in assets and liabilities:
Accounts receivable	(3,518)	(41)
Inventories	135	(510)
Other assets	(570)	461
Accounts payable, accrued expenses and other liabilities	1,955	3,093
Net cash used in operating activities	(6,896)	(4,933)
Cash flows from investing activities:
Capital expenditures	(818)	(780)
Proceeds from the sale of real estate, net of closing costs	0	2,544
Proceeds from the sale of Heritage Labs and Hooper Holmes Services	0	3,289
Costs paid to sell Heritage Labs and Hooper Holmes Services	0	(777)
Acquisition of Accountable Health Solutions	(4,000)	0
Proceeds from the sale of Portamedic	0	743
Net cash (used in) provided by investing activities	(4,818)	5,019
Cash flows from financing activities:
Borrowings under credit facility	8,826	0
Payments under credit facility	(5,431)	0
Proceeds from issuance of Term Loan	5,000	0
Payments on capital lease obligations	0	(4)
Proceeds related to the exercise of stock options	23	30
Debt financing fees	(377)	0
Net cash provided by financing activities	8,041	26
Net decrease in cash and cash equivalents	(3,673)	112
Cash and cash equivalents at beginning of period	5,201	3,970
Cash and cash equivalents at end of period	1,528	4,082
Supplemental disclosure of non-cash investing activities:
Fixed assets vouchered but not paid	130	67
Debt financing fees vouchered but not paid	500	0
Supplemental disclosure of non-cash financing activities:
Issuance of common stock in connection with the Acquisition	$ 3,000	$ 0